Pnc Financial Services Group, Inc. Vaxcyte, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $148 Billion
- Q4 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 9,076 shares of PCVX stock, worth $691,046. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,076
Previous 7,679
18.19%
Holding current value
$691,046
Previous $876,000
15.3%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding PCVX
# of Institutions
350Shares Held
130MCall Options Held
539KPut Options Held
253K-
Vanguard Group Inc Valley Forge, PA12MShares$911 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X010.6MShares$805 Million0.46% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$757 Million0.02% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.69MShares$662 Million11.52% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.21MShares$473 Million0.11% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $4.52B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...